What You'll Do
- Collaborate with product managers and engineers to understand requirements and define test plans.
- Design, write, and execute manual and automated test cases for web and API applications.
- Identify, document, and track software bugs, ensuring clear communication with developers.
- Participate in code reviews and sprint planning to advocate for quality from the start.
- Define and improve QA processes, tools, and metrics as the team and product scale.
What We're Looking For
- At least 2 years of QA or software testing experience.
- Solid understanding of testing methodologies, QA processes, and defect tracking.
- Experience in manual and automated testing.
- Strong troubleshooting and analytical skills.
- Comfortable working in a collaborative, fast-paced environment where you’ll wear multiple hats.
- Bonus: experience in medical software.
About WeInfuse
Come join our growing company. We are an established healthcare SaaS company with offices in Dallas and Austin.
Founded in 2016, WeInfuse is an infusion center software and consulting organization. Our founders and their team have developed the first and only end-to-end software solution for infusion centers that has gained significant traction in the market. In addition to providing the industry’s leading SaaS solution, WeInfuse provides infusion center start-up, optimization and pharmaceutical manufacturer consulting services.
For US-Based Roles: We are not offering new sponsorships opportunities at this time for persons requiring employment visas, such as an H-1B; authorization to work in the U.S. is a precondition of employment. We use E-Verify to confirm the identity and employment eligibility of all new hires.
Any unsolicited resumes/candidate profiles submitted through our website or to personal email accounts of WeInfuse team members are considered the property of WeInfuse and are not subject to payment of agency fees.
What We Do
WeInfuse is a web‐based application that centralizes and streamlines all aspects of infusion center management solving extensive and expensive pain points for the significantly under-resourced channel that delivers specialty biologic infusion medications, the fastest growing segment in pharma.
